Navigation Links
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
Date:7/24/2012

NEW YORK, July 24, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 
http://www.reportlinker.com/p0862093/In-Vitro-Diagnostics-IVD---Emerging-Countries-Brazil-Russia-India-China-Opportunity-Assessment-Competitive-Landscape-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic 

In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the In Vitro Diagnostics (IVD) market in emerging countries. The report provides market landscape, competitive landscape and market trends information on the IVD market in emerging countries. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope 

- Key geographies covered include the China, India, Brazil and Russia.
- Key segments covered include Immuno Chemistry, Infectious Immunology, Clinical Chemistry, Haematology, Histology and Cytology, Genetic Testing and Microbiology Culture.
- Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018. Company shares data for 2011.
- Qualitative analysis of key market trends, market drivers, and restraints within IVD market in emerging countries. 
- The report also covers information on the leading market players and the competitive landscape. 
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sysmex Corporation, Transasia Bio-Medicals Ltd. and Beckman Coulter. 

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the IVD market in emerging countries.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the IVD market in emerging countries? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the IVD market in emerging countries and the factors shaping it.

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 GlobalData Report Guidance 13
3 In Vitro Diagnostics - Device Overview 14
3.1 Immunochemistry 14
3.1.1 Disease-specific Immunochemistry 14
3.1.2 Immunochemistry Analyzers 14
3.1.3 Endocrinology Tests 15
3.1.4 Immunochemistry Rapid Tests 15
3.1.5 Organ Function Assays 15
3.1.6 Anemia/Vitamin Tests 15
3.1.7 Specific Proteins 15
3.1.8 Therapeutic Drug Monitoring 15
3.1.9 Drugs of Abuse/Toxicology 16
3.2 Clinical Chemistry 16
3.2.1 Clinical Chemistry Rapid Tests and Point of Care 16
3.2.2 Clinical Chemistry Analyzers 16
3.2.3 Urine Analysis 16
3.2.4 Metabolite Chemistry Reagents 17
3.2.5 Enzyme Chemistry Reagents 17
3.2.6 Electrolyte Chemistry Reagents 17
3.3 Hematology 17
3.3.1 Hemostasis 17
3.3.2 Hematology Reagents 17
3.3.3 Immunohematology 18
3.3.4 Hematology Rapid Tests 18
3.3.5 Hematology Analyzers 18
3.3.6 Hematology Cell Counters 18
3.4 Infectious Immunology 18
3.4.1 Bacteriology 18
3.4.2 Hepatitis Viruses 18
3.4.3 Other Virology 18
3.4.4 Retroviruses 19
3.5 Microbiology Culture 19
3.5.1 Bacterial Identification and Susceptibility Testing 19
3.5.2 Blood Culture 19
3.5.3 Immunological Culture Identification 19
3.5.4 Microbiology Analyzers 19
3.5.5 Mycobacteria Culture 19
3.5.6 Mycology Culture 19
3.5.7 Parasitology Culture 19
3.6 Histology and Cytology 20
3.6.1 Flow Cytometers 20
3.6.2 Monoclonal Antibodies 20
3.6.3 Tissue Typing Reagents 20
3.7 Genetic Testing 20
3.7.1 Acquired Gene or Chromosome Alterations 20
3.7.2 Inborn Gene or Chromosome Alterations 20
3.7.3 Other Genetic Tests 20
4 In Vitro Diagnostics, Emerging Countries - Market Characterization 21
4.1 In Vitro Diagnostics Market, Emerging Countries (Brazil, Russia, India and China), Historic, Revenue ($m), 2004-2011 21
4.2 In Vitro Diagnostics Market, Emerging Countries (Brazil, Russia, India and China), Revenue ($m), Forecast, 2011-2018 22
4.3 In Vitro Diagnostics Market, Emerging Countries (Brazil, Russia, India and China), Company Shares (%), 2011 23
4.3.1 In Vitro Diagnostics Market, China, Company Share (%), 2011 23
4.3.2 In Vitro Diagnostics Market, India, Company Share (%), 2011 24
4.3.3 In Vitro Diagnostics Market, Brazil, Company Share (%), 2011 25
4.3.4 In Vitro Diagnostics Market, Russia, Company Share (%), 2011 26
4.4 In Vitro Diagnostics Market, Emerging Countries, Key Trends 27
4.4.1 Development of Point of Care Testing Specific to Emerging Countries 27
4.4.2 Consolidation of IVD Market in Emerging Countries through Acquisition of Local Companies by Multi National IVD Companies 28
4.5 In Vitro Diagnostics, Emerging Countries (Brazil, Russia, India and China): Market Dynamics 29
4.5.1 Market Drivers 30
4.5.2 Market Restraints 36
5 In Vitro Diagnostics, Emerging Countries - Category Analysis 38
5.1 Immunochemistry 38
5.2 Immunochemistry Market, Emerging Countries, Revenue ($m), 2004-2018 39
5.2.1 Immunochemistry Market, China, Revenue ($m), Historic, 2004-2011 39
5.2.2 Immunochemistry Market, China, Revenue ($m), Forecast, 2011-2018 40
5.2.3 Immunochemistry Market, India, Revenue ($m), Historic, 2004-2011 41
5.2.4 Immunochemistry Market, India, Revenue ($m), Forecast, 2011-2018 42
5.2.5 Immunochemistry Market, Brazil, Revenue ($m), Historic, 2004-2011 43
5.2.6 Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2011-2018 44
5.2.7 Immunochemistry Market, Russia, Revenue ($m), Historic, 2004-2011 45
5.2.8 Immunochemistry Market, Russia, Revenue ($m), Forecast, 2011-2018 46
5.3 Immunochemistry Market, Emerging Countries (Brazil, Russia, India and China), Company Shares (%), 2011 47
5.3.1 Immunochemistry Market, China, Company Share (%), 2011 47
5.3.2 Immunochemistry Market, India, Company Share (%), 2011 48
5.3.3 Immunochemistry Market, Brazil, Company Share (%), 2011 49
5.3.4 Immunochemistry Market, Russia, Company Share (%), 2011 50
5.4 Immunochemistry, Emerging Countries: Market Dynamics 51
5.4.1 Market Drivers 51
5.4.2 Market Restraint 54
5.5 Clinical Chemistry 54
5.6 Clinical Chemistry Market, Emerging Countries, Revenue ($m), 2004-2018 55
5.6.1 Clinical Chemistry Market, China, Revenue ($m), Historic, 2004-2011 55
5.6.2 Clinical Chemistry Market, China, Revenue ($m), Forecast, 2011-2018 56
5.6.3 Clinical Chemistry Market, India, Revenue ($m), Historic, 2004-2011 57
5.6.4 Clinical Chemistry Market, India, Revenue ($m), Forecast, 2011-2018 58
5.6.5 Clinical Chemistry Market, Brazil, Revenue ($m), Historic, 2004-2011 59
5.6.6 Clinical Chemistry Market, Brazil, Revenue ($m), Forecast, 2011-2018 60
5.6.7 Clinical Chemistry Market, Russia, Revenue ($m), Historic, 2004-2011 61
5.6.8 Clinical Chemistry Market, Russia, Revenue ($m), Forecast, 2011-2018 62
5.7 Clinical Chemistry Market, Emerging Countries (Brazil, Russia, India and China), Company Shares (%), 2011 63
5.7.1 Clinical Chemistry Market, China, Company Share (%), 2011 63
5.7.2 Clinical Chemistry Market, India, Company Share (%), 2011 64
5.7.3 Clinical Chemistry Market, Brazil, Company Share (%), 2011 65
5.7.4 Clinical Chemistry Market, Russia, Company Share (%), 2011 66
5.8 Clinical Chemistry, Emerging Countries: Market Dynamics 67
5.8.1 Market Driver 67
5.8.2 Market Restraint 67
5.9 Hematology 68
5.10 Hematology Market, Emerging Countries, Revenue ($m), 2004-2018 69
5.10.1 Hematology Market, China, Revenue ($m), Historic, 2004-2011 69
5.10.2 Hematology Market, China, Revenue ($m), Forecast, 2011-2018 70
5.10.3 Hematology Market, India, Revenue ($m), Historic, 2004-2011 71
5.10.4 Hematology Market, India, Revenue ($m), Forecast, 2011-2018 72
5.10.5 Hematology Market, Brazil, Revenue ($m), Historic, 2004-2011 73
5.10.6 Hematology Market, Brazil, Revenue ($m), Forecast, 2011-2018 74
5.10.7 Hematology Market, Russia, Revenue ($m), Historic, 2004-2011 75
5.10.8 Hematology Market, Russia, Revenue ($m), Forecast, 2011-2018 76
5.11 Hematology Market, Emerging Countries (Brazil, Russia, India and China), Company Shares (%), 2011 77
5.11.1 Hematology Market, China, Company Share (%), 2011 77
5.11.2 Hematology Market, India, Company Share (%), 2011 78
5.11.3 Hematology Market, Brazil, Company Share (%), 2011 79
5.11.4 Hematology Market, Russia, Company Share (%), 2011 80
5.12 Hematology Emerging Countries: Market Dynamics 81
5.12.1 Market Driver 81
5.12.2 Market Restraint 82
5.13 Infectious Immunology 82
5.14 Infectious Immunology Market, Emerging Countries, Revenue ($m), 2004-2018 83
5.14.1 Infectious Immunology Market, China, Revenue ($m), Historic, 2004-2011 83
5.14.2 Infectious Immunology Market, China, Revenue ($m), Forecast, 2011-2018 84
5.14.3 Infectious Immunology Market, India, Revenue ($m), Historic, 2004-2011 85
5.14.4 Infectious Immunology Market, India, Revenue ($m), Forecast, 2011-2018 86
5.14.5 Infectious Immunology Market, Brazil, Revenue ($m), Historic, 2004-2011 87
5.14.6 Infectious Immunology Market, Brazil, Revenue ($m), Forecast, 2011-2018 88
5.14.7 Infectious Immunology Market, Russia, Revenue ($m), Historic, 2004-2011 89
5.14.8 Infectious Immunology Market, Russia, Revenue ($m), Forecast, 2011-2018 90
5.15 Infectious Immunology Market, Emerging Countries (Brazil, Russia, India and China), Company Share (%), 2011 91
5.15.1 Infectious Immunology Market, China, Company Share (%), 2011 91
5.15.2 Infectious Immunology Market, India, Company Share (%), 2011 92
5.15.3 Infectious Immunology Market, Brazil, Company Share (%), 2011 93
5.15.4 Infectious Immunology Market, Russia, Company Share (%), 2011 94
5.16 Infectious Immunology, Emerging Countries: Market Dynamics 95
5.16.1 Market Drivers 95
5.16.2 Market Restraint 97
5.17 Microbiology Culture 97
5.18 Microbiology Culture Market, Emerging Countries, Revenue ($m), 2004-2018 98
5.18.1 Microbiology Culture Market, China, Revenue ($m), Historic, 2004-2011 98
5.18.2 Microbiology Culture Market, China, Revenue ($m), Forecast, 2011-2018 99
5.18.3 Microbiology Culture Market, India, Revenue ($m), Historic, 2004-2011 100
5.18.4 Microbiology Culture Market, India, Revenue ($m), Forecast, 2011-2018 101
5.18.5 Microbiology Culture Market, Brazil, Revenue ($m), Historic, 2004-2011 102
5.18.6 Microbiology Culture Market, Brazil, Revenue ($m), Forecast, 2011-2018 103
5.18.7 Microbiology Culture Market, Russia, Revenue ($m), Historic, 2004-2011 104
5.18.8 Microbiology Culture Market, Russia, Revenue ($m), Forecast, 2011-2018 105
5.19 Microbiology Culture Market, Emerging Countries (Brazil, Russia, India and China), Company Share (%), 2011 106
5.19.1 Microbiology Culture Market, China, Company Share (%), 2011 106
5.19.2 Microbiology Culture Market, India, Company Share (%), 2011 107
5.19.3 Microbiology Culture Market, Brazil, Company Share (%), 2011 108
5.19.4 Microbiology Culture Market, Russia, Company Share (%), 2011 109
5.20 Microbiology Culture, Emerging Countries: Market Dynamics 110
5.20.1 Market Drivers 110
5.20.2 Market Restraint 111
5.21 Histology and Cytology 112
5.22 Histology and Cytology Market, Emerging Countries, Revenue ($m), 2004-2018 112
5.22.1 Histology and Cytology Market, China, Revenue ($m), Historic, 2004-2011 112
5.22.2 Histology and Cytology Market, China, Revenue ($m), Forecast, 2011-2018 114
5.22.3 Histology and Cytology Market, India, Revenue ($m), Historic, 2004-2011 115
5.22.4 Histology and Cytology Market, India, Revenue ($m), Forecast, 2011-2018 116
5.22.5 Histology and Cytology Market, Brazil, Revenue ($m), Historic, 2004-2011 117
5.22.6 Histology and Cytology Market, Brazil, Revenue ($m), Forecast, 2011-2018 118
5.22.7 Histology and Cytology Market, Russia, Revenue ($m), Historic, 2004-2011 119
5.22.8 Histology and Cytology Market, Russia, Revenue ($m), Forecast, 2011-2018 120
5.23 Histology and Cytology Market, Emerging Countries (Brazil, Russia, India and China), Company Share (%), 2011 121
5.23.1 Histology and Cytology Market, China, Company Share (%), 2011 121
5.23.2 Histology and Cytology Market, India, Company Share (%), 2011 122
5.23.3 Histology and Cytology Market, Brazil, Company Share (%), 2011 123
5.23.4 Histology and Cytology Market, Russia, Company Share (%), 2011 124
5.24 Histology and Cytology, Emerging Countries: Market Dynamics 125
5.24.1 Market Driver 125
5.24.2 Market Restraint 125
5.25 Genetic Testing 126
5.26 Genetic Testing Market, Emerging Countries, Revenue ($m), 2004-2018 126
5.26.1 Genetic Testing Market, China, Revenue ($m), Historic, 2004-2011 126
5.26.2 Genetic Testing Market, China, Revenue ($m), Forecast, 2011-2018 127
5.26.3 Genetic Testing Market, India, Revenue ($m), Historic, 2004-2011 128
5.26.4 Genetic Testing Market, India, Revenue ($m), Forecast, 2011-2018 129
5.26.5 Genetic Testing Market, Brazil, Revenue ($m), Historic, 2004-2011 130
5.26.6 Genetic Testing Market, Brazil, Revenue ($m), Forecast, 2011-2018 131
5.26.7 Genetic Testing Market, Russia, Revenue ($m), Historic, 2004-2011 132
5.26.8 Genetic Testing Market, Russia, Revenue ($m), Forecast, 2011-2018 133
5.27 Genetic Testing Market, Emerging Countries (Brazil, Russia, India and China), Company Shares (%), 2011 134
5.27.1 Genetic Testing Market, China, Company Share (%), 2011 134
5.27.2 Genetic Testing Market, India, Company Share (%), 2011 135
5.27.3 Genetic Testing Market, Brazil, Company Share (%), 2011 136
5.27.4 Genetic Testing Market, Russia, Company Share (%), 2011 137
5.28 Genetic Testing, Emerging Countries: Market Dynamics 138
5.28.1 Market Drivers 138
5.28.2 Market Restraint 139
6 In Vitro Diagnostics Market, Emerging Countries (Brazil, Russia, India and China) - Strategic Competitive Assessment 140
6.1 In Vitro Diagnostics, Key Market Participants 143
6.1.1 Siemens Healthcare 143
6.1.2 F. Hoffmann-La Roche Ltd. 145
6.1.3 Abbott Laboratories 148
6.1.4 Sysmex Corporation 149
6.1.5 Transasia Bio-Medicals Ltd. 151
6.1.6 Beckman Coulter, Inc. 153
7 In Vitro Diagnostics Market, Emerging Countries - Strategic Pipeline Assessment 156
7.1 Profiles of Promising Products under Clinical Development: In Vitro Diagnostics - Immunochemistry 156
7.1.1 AUTOLIA-12/48 157
7.1.2 FISH Diagnostic Test - Infertility 157
7.1.3 ColonSentry 158
7.1.4 OvPlex 158
7.1.5 Diagnostic Test - Breast Cancer 159
7.2 Profiles of Promising Products under Clinical Development: In Vitro Diagnostics - Hematology 159
7.2.1 Premier Hb9210 Analyzer 159
7.2.2 Cobas b 123 POC System 160
7.3 Profiles of Promising Products under Clinical Development: In Vitro Diagnostics - Infectious Immunology 160
7.3.1 CareHPV Assay 161
7.3.2 Rheonix CARD HPV Assay 161
7.3.3 Diagnostic Test - Dengue Fever Virus 161
7.3.4 Immunodiagnostic Assay - HCVA 162
7.4 Profiles of Promising Products under Clinical Development: In Vitro Diagnostics - Genetic Testing 162
7.4.1 FISH Diagnostic Test - Miscarriage 163
7.4.2 MDR TB Diagnostic Assay 163
7.4.3 G6PD Genotyping Assay 164
7.4.4 MeltPro HBB Diagnostic Kit 164
7.4.5 HPV Genotyping Assay 165
8 In Vitro Diagnostics Market - Mergers and Acquisitions Landscape, 2007-2011 166
8.1 In Vitro Diagnostics Market: Key Acquisitions, 2007-2011 167
8.1.1 Mindray Medical International to Acquire Hunan Changsha Tiandiren Biotech 167
8.1.2 CCS Capital Acquired Beijing Biochem Hengye Science and Technology 167
8.1.3 bioMerieux Completed Acquisition of Meikang Biotech (Shanghai) 167
8.1.4 PerkinElmer Completed Acquisition of Sym-Bio LifeScience 168
8.1.5 China Medical Technologies Acquired Beijing Bio-Ekon Biotechnology 168
9 Appendix 169
9.1 Definitions 169
9.1.1 In Vitro Diagnostics 169
9.1.2 Immunochemistry 169
9.1.3 Clinical Chemistry 170
9.1.4 Hematology 170
9.1.5 Infectious Immunology 170
9.1.6 Microbiology Culture 170
9.1.7 Histology and Cytology 170
9.1.8 Genetic Testing 170
9.2 Acronyms 171
9.3 Sources 173
9.4 Research Methodology 174
9.5 Secondary Research 174
9.6 Primary Research 175
9.7 Models 175
9.8 Forecasts 175
9.9 Expert Panels 175
9.10 GlobalData Consulting 176
9.11 Contact Us 176
9.12 Disclaimer 176

List of Tables

Table 1: In Vitro Diagnostics Market, Emerging Countries, Revenue ($m), 2004-2011 21
Table 2: In Vitro Diagnostics Market, Emerging Countries, Revenue ($m), 2011-2018 22
Table 3: List of Private Equity/Venture Capital Investments and Collaborations in In Vitro Diagnostics (BRIC), 2011 33
Table 4: Percentage of People Aged 65 Years and Above in Total Adult Population, by Country (%), 1980-2050 35
Table 5: Immunochemistry Market, China, Revenue ($m), 2004-2011 39
Table 6: Immunochemistry Market, China, Revenue ($m), 2011-2018 40
Table 7: Immunochemistry Market, India, Revenue ($m), 2004-2011 41
Table 8: Immunochemistry Market, India, Revenue ($m), 2011-2018 42
Table 9: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011 43
Table 10: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018 44
Table 11: Immunochemistry Market, Russia, Revenue ($m), 2004-2011 45
Table 12: Immunochemistry Market, Russia, Revenue ($m), 2011-2018 46
Table 13: Immunochemistry Market, China, Company Revenue ($m), 2011 47
Table 14: Immunochemistry Market, India, Company Revenue ($m), 2011 48
Table 15: Immunochemistry Market, Brazil, Company Revenue ($m), 2011 49
Table 16: Immunochemistry Market, Russia, Company Revenue ($m), 2011 50
Table 17: Total fertility rate, Emerging Countries (BRIC), 1970 - 2009 51
Table 18: Cardiovascular Deaths in China and India, 2012 53
Table 19: Clinical Chemistry Market, China, Revenue ($m), 2004-2011 55
Table 20: Clinical Chemistry Market, China, Revenue ($m), 2011-2018 56
Table 21: Clinical Chemistry Market, India, Revenue ($m), 2004-2011 57
Table 22: Clinical Chemistry Market, India, Revenue ($m), 2011-2018 58
Table 23: Clinical Chemistry Market, Brazil, Revenue ($m), 2004-2011 59
Table 24: Clinical Chemistry Market, Brazil, Revenue ($m), 2011-2018 60
Table 25: Clinical Chemistry Market, Russia, Revenue ($m), 2004-2011 61
Table 26: Clinical Chemistry Market, Russia, Revenue ($m), 2011-2018 62
Table 27: Clinical Chemistry Market, China, Company Revenue ($m), 2011 63
Table 28: Clinical Chemistry Market, India, Company Revenue ($m), 2011 64
Table 29: Clinical Chemistry Market, Brazil, Company Revenue ($m), 2011 65
Table 30: Clinical Chemistry Market, Russia, Company Revenue ($m), 2011 66
Table 31: Hematology Market, China, Revenue ($m), 2004-2011 69
Table 32: Hematology Market, China, Revenue ($m), 2011-2018 70
Table 33: Hematology Market, India, Revenue ($m), 2004-2011 71
Table 34: Hematology Market, India, Revenue ($m), 2011-2018 72
Table 35: Hematology Market, Brazil, Revenue ($m), 2004-2011 73
Table 36: Hematology Market, Brazil, Revenue ($m), 2011-2018 74
Table 37: Hematology Market, Russia, Revenue ($m), 2004-2011 75
Table 38: Hematology Market, Russia, Revenue ($m), 2011-2018 76
Table 39: Hematology Market, China, Company Revenue ($m), 2011 77
Table 40: Hematology Market, India, Company Revenue ($m), 2011 78
Table 41: Hematology Market, Brazil, Company Revenue ($m), 2011 79
Table 42: Hematology Market, Russia, Company Revenue ($m), 2011 80
Table 43: Infectious Immunology Market, China, Revenue ($m), 2004-2011 83
Table 44: Infectious Immunology Market, China, Revenue ($m), 2011-2018 84
Table 45: Infectious Immunology Market, India, Revenue ($m), 2004-2011 85
Table 46: Infectious Immunology Market, India, Revenue ($m), 2011-2018 86
Table 47: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011 87
Table 48: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018 88
Table 49: Infectious Immunology Market, Russia, Revenue ($m), 2004-2011 89
Table 50: Infectious Immunology Market, Russia, Revenue ($m), 2011-2018 90
Table 51: Infectious Immunology Market, China, Company Revenue ($m), 2011 91
Table 52: Infectious Immunology Market, India, Company Revenue ($m), 2011 92
Table 53: Infectious Immunology Market, Brazil, Company Revenue ($m), 2011 93
Table 54: Infectious Immunology Market, Russia, Company Revenue ($m), 2011 94
Table 55: Microbiology Culture Market, China, Revenue ($m), 2004-2011 98
Table 56: Microbiology Culture Market, China, Revenue ($m), 2011-2018 99
Table 57: Microbiology Culture Market, India, Revenue ($m), 2004-2011 100
Table 58: Microbiology Culture Market, India, Revenue ($m), 2011-2018 101
Table 59: Microbiology Culture Market, Brazil, Revenue ($m), 2004-2011 102
Table 60: Microbiology Culture Market, Brazil, Revenue ($m), 2011-2018 103
Table 61: Microbiology Culture Market, Russia, Revenue ($m), 2004-2011 104
Table 62: Microbiology Culture Market, Russia, Revenue ($m), 2011-2018 105
Table 63: Microbiology Culture Market, China, Company Revenue ($m), 2011 106
Table 64: Microbiology Culture Market, India, Company Revenue ($m), 2011 107
Table 65: Microbiology Culture Market, Brazil, Company Revenue ($m), 2011 108
Table 66: Microbiology Culture Market, Russia, Company Revenue ($m), 2011 109
Table 67: Prevalence of Tuberculosis (per 100,000 population), BRIC, 2012 110
Table 68: Histology and Cytology Market, China, Revenue ($m), 2004-2011 113
Table 69: Histology and Cytology Market, China, Revenue ($m), 2011-2018 114
Table 70: Histology and Cytology Market, India, Revenue ($m), 2004-2011 115
Table 71: Histology and Cytology Market, India, Revenue ($m), 2011-2018 116
Table 72: Histology and Cytology Market, Brazil, Revenue ($m), 2004-2011 117
Table 73: Histology and Cytology Market, Brazil, Revenue ($m), 2011-2018 118
Table 74: Histology and Cytology Market, Russia, Revenue ($m), 2004-2011 119
Table 75: Histology and Cytology Market, Russia, Revenue ($m), 2011-2018 120
Table 76: Histology and Cytology Market, China, Company Revenue ($m), 2011 121
Table 77: Histology and Cytology Market, India, Company Revenue ($m), 2011 122
Table 78: Histology and Cytology Market, Brazil, Company Revenue ($m), 2011 123
Table 79: Histology and Cytology Market, Russia, Company Revenue ($m), 2011 124
Table 80: Genetic Testing Market, China, Revenue ($m), 2004-2011 126
Table 81: Genetic Testing Market, China, Revenue ($m), 2011-2018 127
Table 82: Genetic Testing Market, India, Revenue ($m), 2004-2011 128
Table 83: Genetic Testing Market, India, Revenue ($m), 2011-2018 129
Table 84: Genetic Testing Market, Brazil, Revenue ($m), 2004-2011 130
Table 85: Genetic Testing Market, Brazil, Revenue ($m), 2011-2018 131
Table 86: Genetic Testing Market, Russia, Revenue ($m), 2004-2011 132
Table 87: Genetic Testing Market, Russia, Revenue ($m), 2011-2018 133
Table 88: Genetic Testing Market, China, Company Revenue ($m), 2011 134
Table 89: Genetic Testing Market, India, Company Revenue ($m), 2011 135
Table 90: Genetic Testing Market, Brazil, Company Revenue ($m), 2011 136
Table 91: Genetic Testing Market, Russia, Company Revenue ($m), 2011 137
Table 92: Consanguineous Marriage in China and India, 2012 138
Table 93: Siemens Healthcare, Key Marketed Products, 2011 143
Table 94: F. Hoffmann-La Roche Ltd., Key Marketed Products, 2011 146
Table 95: Abbott Laboratories, Key Marketed Products, 2011 148
Table 96: Sysmex Corporation, Key Marketed Products, 2011 150
Table 97: Transasia Bio-Medicals Ltd., Key Marketed Products, 2011 152
Table 98: Beckman Coulter, Inc., Key Marketed Products, 2011 154
Table 99: Immunochemistry Market, Emerging Countries, List of Pipeline Products, 2012 156
Table 100: AUTOLIA-12/48, Product Status, 2011 157
Table 101: FISH Diagnostic Test - Infertility, Product Status, 2012 157
Table 102: ColonSentry, Product Status, 2012 158
Table 103: OvPlex, Product Status, 2011 158
Table 104: Diagnostic Test - Breast Cancer, Product Status, 2011 159
Table 105: Hematology Market, Emerging Countries, List Of Pipeline Products, 2012 159
Table 106: Premier Hb9210 Analyzer, Product Status, 2012 159
Table 107: Cobas b 123 POC System, Product Status, 2012 160
Table 108: In Vitro Diagnostics Market, Emerging Countries, List Of Pipeline Products, 2012 160
Table 109: CareHPV Assay, Product Status, 2012 161
Table 110: Rheonix CARD HPV Assay, Product Status, 2012 161
Table 111: Diagnostic Test - Dengue Fever Virus, Product Status, 2012 161
Table 112: Immunodiagnostic Assay - HCVA, Product Status, 2012 162
Table 113: In Vitro Diagnostics Market, Emerging Countries, List Of Pipeline Products, 2012 162
Table 114: FISH Diagnostic Test - Miscarriage, Product Status, 2011 163
Table 115: MDR TB Diagnostic Assay, Product Status, 2012 163
Table 116: G6PD Genotyping Assay, Product Status, 2012 164
Table 117: MeltPro HBB Diagnostic Kit, Product Status, 2011 164
Table 118: HPV Genotyping AssayProduct, Product Status, 2011 165
Table 119: In Vitro Diagnostics Market, Emerging Countries, Mergers and Acquisitions, 2007-2011 166

List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation, 2012 14
Figure 2: In Vitro Diagnostics Market, Emerging Countries (Brazil, Russia, India and China), Revenue ($m), 2004-2011 21
Figure 3: In Vitro Diagnostics Market, Emerging Countries (Brazil, Russia, India and China), Revenue ($m), 2011-2018 22
Figure 4: In Vitro Diagnostics Market, China, Company Share (%), 2011 23
Figure 5: In Vitro Diagnostics Market, India, Company Share (%), 2011 24
Figure 6: In Vitro Diagnostics Market, Brazil, Company Share (%), 2011 25
Figure 7: In Vitro Diagnostics Market, Russia, Company Share (%), 2011 26
Figure 8: In Vitro Diagnostics Market, BRIC - Key Market Trends, 2011 27
Figure 9: In Vitro Diagnostics Market, Mergers and Acquisitions, Volume, Emerging Countries (BRIC), 2008-2011 28
Figure 10: In Vitro Diagnostics, Market Dynamics, 2012 29
Figure 11: Per Capita Expenditure on Healthcare, Emerging Countries (Brazil, Russia, India and China), 2000-2009 30
Figure 12: Key Hospital Groups or Organizations Planning Expansion in Tier II and Tier III Cities in India and China, 2011 32
Figure 13: Percentage of People Aged 65 and Over in Total Adult Population, by Country (%), 1980-2050 35
Figure 14: Immunochemistry, Market Segmentation, 2012 38
Figure 15: Immunochemistry Market, China, Revenue ($m), 2004-2011 39
Figure 16: Immunochemistry Market, China, Revenue ($m), 2011-2018 40
Figure 17: Immunochemistry Market, India, Revenue ($m), 2004-2011 41
Figure 18: Immunochemistry Market, India, Revenue ($m), 2011-2018 42
Figure 19: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011 43
Figure 20: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018 44
Figure 21: Immunochemistry Market, Russia, Revenue ($m), 2004-2011 45
Figure 22: Immunochemistry Market, Russia, Revenue ($m), 2011-2018 46
Figure 23: Immunochemistry Market, China, Company Share (%), 2011 47
Figure 24: Immunochemistry Market, India, Company Share (%), 2011 48
Figure 25: Immunochemistry Market, Brazil, Company Share (%), 2011 49
Figure 26: Immunochemistry Market, Russia, Company Share (%), 2011 50
Figure 27: Total Fertility Rate, Emerging Countries (BRIC), 1970 - 2009 51
Figure 28: Cardiovascular Deaths in China and India, 2012 53
Figure 29: Clinical Chemistry Market Segmentation, 2012 54
Figure 30: Clinical Chemistry Market, China, Revenue ($m), 2004-2011 55
Figure 31: Clinical Chemistry Market, China, Revenue ($m), 2011-2018 56
Figure 32: Clinical Chemistry Market, India, Revenue ($m), 2004-2011 57
Figure 33: Clinical Chemistry Market, India, Revenue ($m), 2011-2018 58
Figure 34: Clinical Chemistry Market, Brazil, Revenue ($m), 2004-2011 59
Figure 35: Clinical Chemistry Market, Brazil, Revenue ($m), 2011-2018 60
Figure 36: Clinical Chemistry Market, Russia, Revenue ($m), 2004-2011 61
Figure 37: Clinical Chemistry Market, Russia, Revenue ($m), 2011-2018 62
Figure 38: Clinical Chemistry Market, China, Company Share (%), 2011 63
Figure 39: Clinical Chemistry Market, India, Company Share (%), 2011 64
Figure 40: Clinical Chemistry Market, Brazil, Company Share (%), 2011 65
Figure 41: Clinical Chemistry Market, Russia, Company Share (%), 2011 66
Figure 42: Hematology, Market Segmentation, 2012 68
Figure 43: Hematology Market, China, Revenue ($m), 2004-2011 69
Figure 44: Hematology Market, China, Revenue ($m), 2011-2018 70
Figure 45: Hematology Market, India, Revenue ($m), 2004-2011 71
Figure 46: Hematology Market, India, Revenue ($m), 2011-2018 72
Figure 47: Hematology Market, Brazil, Revenue ($m), 2004-2011 73
Figure 48: Hematology Market, Brazil, Revenue ($m), 2011-2018 74
Figure 49: Hematology Market, Brazil, Revenue ($m), 2004-2011 75
Figure 50: Hematology Market, Brazil, Revenue ($m), 2011-2018 76
Figure 51: Hematology Market, China, Company Share (%), 2011 77
Figure 52: Hematology Market, India, Company Share (%), 2011 78
Figure 53: Hematology Market, Brazil, Company Share (%), 2011 79
Figure 54: Hematology Market, Russia, Company Share (%), 2011 80
Figure 55: Infectious Immunology, Market Segmentation, 2012 82
Figure 56: Infectious Immunology Market, China, Revenue ($m), 2004-2011 83
Figure 57: Infectious Immunology Market, China, Revenue ($m), 2011-2018 84
Figure 58: Infectious Immunology Market, India, Revenue ($m), 2004-2011 85
Figure 59: Infectious Immunology Market, India, Revenue ($m), 2011-2018 86
Figure 60: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011 87
Figure 61: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018 88
Figure 62: Infectious Immunology Market, Russia, Revenue ($m), 2004-2011 89
Figure 63: Infectious Immunology Market, Russia, Revenue ($m), 2011-2018 90
Figure 64: Infectious Immunology Market, China, Company Share (%), 2011 91
Figure 65: Infectious Immunology Market, India, Company Share (%), 2011 92
Figure 66: Infectious Immunology Market, Brazil, Company Share (%), 2011 93
Figure 67: Infectious Immunology Market, Russia, Company Share (%), 2011 94
Figure 68: Microbiology Culture, Market Segmentation, 2012 97
Figure 69: Microbiology Culture Market, China, Revenue ($m), 2004-2011 98
Figure 70: Microbiology Culture Market, China, Revenue ($m), 2011-2018 99
Figure 71: Microbiology Culture Market, India, Revenue ($m), 2004-2011 100
Figure 72: Microbiology Culture Market, India, Revenue ($m), 2011-2018 101
Figure 73: Microbiology Culture Market, Brazil, Revenue ($m), 2004-2011 102
Figure 74: Microbiology Culture Market, Brazil, Revenue ($m), 2011-2018 103
Figure 75: Microbiology Culture Market, Russia, Revenue ($m), 2004-2011 104
Figure 76: Microbiology Culture Market, Russia, Revenue ($m), 2011-2018 105
Figure 77: Microbiology Culture Market, China, Company Share (%), 2011 106
Figure 78: Microbiology Culture Market, India, Company Share (%), 2011 107
Figure 79: Microbiology Culture Market, Brazil, Company Share (%), 2011 108
Figure 80: Microbiology Culture Market, Russia, Company Share (%), 2011 109
Figure 81: Prevalence of tuberculosis (per 100,000 population), BRIC, 2012 110
Figure 82: Histology and Cytology, Market Segmentation, 2012 112
Figure 83: Histology and Cytology Market, China, Revenue ($m), 2004-2011 112
Figure 84: Histology and Cytology Market, China, Revenue ($m), 2011-2018 114
Figure 85: Histology and Cytology Market, India, Revenue ($m), 2004-2011 115
Figure 86: Histology and Cytology Market, India, Revenue ($m), 2011-2018 116
Figure 87: Histology and Cytology Market, Brazil, Revenue ($m), 2004-2011 117
Figure 88: Histology and Cytology Market, Brazil, Revenue ($m), 2011-2018 118
Figure 89: Histology and Cytology Market, Russia, Revenue ($m), 2004-2011 119
Figure 90: Histology and Cytology Market, Russia, Revenue ($m), 2011-2018 120
Figure 91: Histology and Cytology Market, China, Company Share (%), 2011 121
Figure 92: Histology and Cytology Market, India, Company Share (%), 2011 122
Figure 93: Histology and Cytology Market, Brazil, Company Share (%), 2011 123
Figure 94: Histology and Cytology Market, Russia, Company Share (%), 2011 124
Figure 95: Genetic Testing, Market Segmentation, 2012 126
Figure 96: Genetic Testing Market, China, Revenue ($m), 2004-2011 126
Figure 97: Genetic Testing Market, China, Revenue ($m), 2011-2018 127
Figure 98: Genetic Testing Market, India, Revenue ($m), 2004-2011 128
Figure 99: Genetic Testing Market, India, Revenue ($m), 2011-2018 129
Figure 100: Genetic Testing Market, Brazil, Revenue ($m), 2004-2011 130
Figure 101: Genetic Testing Market, Brazil, Revenue ($m), 2011-2018 131
Figure 102: Genetic Testing Market, Russia, Revenue ($m), 2004-2011 132
Figure 103: Genetic Testing Market, Russia, Revenue ($m), 2011-2018 133
Figure 104: Genetic Testing Market, China, Company Share (%), 2011 134
Figure 105: Genetic Testing Market, India, Company Share (%), 2011 135
Figure 106: Genetic Testing Market, Brazil, Company Share (%), 2011 136
Figure 107: Genetic Testing Market, Russia, Company Share (%), 2011 137
Figure 108: In Vitro Diagnostics Market, China, Competitive Assessment, 2011 140
Figure 109: In Vitro Diagnostics Market, India, Competitive Assessment, 2011 141
Figure 110: In Vitro Diagnostics Market, Brazil, Competitive Assessment, 2011 141
Figure 111: In Vitro Diagnostics Market, Russia, Competitive Assessment, 2011 142
Figure 112: Siemens Healthcare, Internal Factors Evaluation 144
Figure 113: F. Hoffmann-La Roche Ltd., Internal Factors Evaluation 146
Figure 114: Abbott Laboratories, Internal Factors Evaluation 148
Figure 115: Sysmex Corporation, Internal Factors Evaluation 150
Figure 116: Transasia Bio-Medicals Ltd., Internal Factors Evaluation 152
Figure 117: Beckman Coulter, Inc., Internal Factors Evaluation 154

Companies mentioned 
Siemens Healthcare
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Sysmex Corporation
Transasia Bio-Medicals Ltd.
Beckman Coulter, Inc.

To order this report:
In Vitro Diagnostic Industry: In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 

More Market Research Report 
Check our Industry Analysis and Insights 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related biology technology :

1. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
2. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
3. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
4. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
5. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
6. Comprehensive Resource for Food Safety Diagnostics – Romer Labs Launches New Website
7. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
8. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
9. Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer
10. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
11. Ariosa Diagnostics Announces Nationwide Launch of the Harmony™ Prenatal Test Through LabCorp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12, 2016 MedGenome,s Commitment ... Scientific Understanding of Complex Diseases Such as Cancer, ... --> --> MedGenome, ... and a leading provider of genomics research services ... to the GenomeAsia 100K consortium as a founding ...
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016  Bioethics International, ... how medicines are researched, developed, marketed and made accessible to ... BMJ Open had named the publication of the ... for 2015. The publication is also featured as one of ... published in the last year that are most frequently read. ...
(Date:2/11/2016)... , February 11, 2016 ... Corporation ("PositiveID" or "Company") (OTCQB: PSID), a life ... today that its Thermomedics subsidiary, which markets the ... its growth plan in January 2016, including entering ... increasing sequential monthly sales growth, and establishing several ...
(Date:2/10/2016)... MONTREAL , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. ... is pleased to announce that Mitsui & Co. Ltd., ... bio-based succinic acid plant, is investing an additional CDN$25 ... equity, increasing its stake from 30% to 40%.  Mitsui ... of bio-succinic acid produced in Sarnia ...
Breaking Biology Technology:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... 20, 2016 A market that just keeps ... from the explosion in genomics knowledge. Learn all about ... A range of dynamic trends are pushing market growth ... medicine - pharmacogenomics - pathogen evolution - next generation ... - greater understanding of the role of genetic material ...
(Date:1/20/2016)... 20, 2016  Synaptics Incorporated (NASDAQ: SYNA ... today announced sampling of S1423, its newest ClearPad ... small screen applications including smartwatches, fitness trackers, and ... and rectangular shapes, as well as thick and ... moisture on screen, while wearing gloves, and supports ...
Breaking Biology News(10 mins):